VACCINER AF VIRUSLIGNENDE PARTIKEL (VLP) AF HUNDEPARVOVIRUS (CPV) OG ANVENDELSER DERAF

The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protei...

Full description

Saved in:
Bibliographic Details
Main Authors POULET, Hervé, DAVID, Frederic, HANNAS-DJEBBARA, Zahia, MINKE, Jules, Maarten
Format Patent
LanguageDanish
Published 30.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protein. Further, the invention broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.
Bibliography:Application Number: DK20160771050T